ANIKA THERAPEUTICS, INC. 8-K

Company

Anika Therapeutics, Inc.

Filed

June 6, 2014

Period of Report

June 5, 2014

Accession Number

0001157523-14-002485

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →